Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

BACKGROUND: We assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients with locally advanced (LA) or metastatic (M) (advanced) biliary cancers (ABC) for whom there is no standard chemotherapy. METHODS: Patients, aged ⩾18 years, with pathologically confirmed ABC, Karnofsk...

Descripción completa

Detalles Bibliográficos
Autores principales: Valle, J W, Wasan, H, Johnson, P, Jones, E, Dixon, L, Swindell, R, Baka, S, Maraveyas, A, Corrie, P, Falk, S, Gollins, S, Lofts, F, Evans, L, Meyer, T, Anthoney, A, Iveson, T, Highley, M, Osborne, R, Bridgewater, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736816/
https://www.ncbi.nlm.nih.gov/pubmed/19672264
http://dx.doi.org/10.1038/sj.bjc.6605211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736816/
https://www.ncbi.nlm.nih.gov/pubmed/19672264
http://dx.doi.org/10.1038/sj.bjc.6605211

Ejemplares similares